Voloridge Investment Management
COLL icon

Voloridge Investment Management’s Collegium Pharmaceutical COLL Stock Holding History

Voloridge Investment Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.62M Sell
200,306
-47,369
-19% -$2.01M 0.03% 615
2025
Q4 		$11.5M Sell
247,675
-1,798
-0.7% -$75.2K 0.04% 543
2025
Q3 		$8.73M Buy
249,473
+223,329
+854% +$7.76M 0.03% 578
2025
Q2 		$773K Buy
+26,144
New +$746K ﹤0.01% 1047
2024
Q4 		– Sell
-15,131
Closed -$585K – 1210
2024
Q3 		$585K Buy
+15,131
New +$540K ﹤0.01% 1070
2023
Q4 		– Sell
-29,922
Closed -$669K – 1214
2023
Q3 		$669K Sell
29,922
-76,041
-72% -$1.73M ﹤0.01% 1166
2023
Q2 		$2.28M Sell
105,963
-18,178
-15% -$413K 0.01% 946
2023
Q1 		$2.98M Buy
+124,141
New +$3.29M 0.01% 847
2020
Q4 		– Sell
-37,244
Closed -$775K – 1353
2020
Q3 		$775K Buy
+37,244
New +$672K 0.01% 1008
2020
Q2 		– Sell
-18,773
Closed -$307K – 1291
2020
Q1 		$307K Buy
18,773
+4,597
+32% +$94.9K 0.01% 861
2019
Q4 		$292K Buy
+14,176
New +$236K 0.01% 940
2019
Q2 		– Sell
-21,212
Closed -$321K – 798
2019
Q1 		$321K Buy
+21,212
New +$340K 0.01% 788

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Voloridge Investment Management's COLL Position: Q1 2026 in Review

Voloridge Investment Management reduced its Collegium Pharmaceutical (COLL) stake by 19% in Q1 2026, selling an estimated $2.01M and leaving 200,306 shares worth $6.62M. The position accounts for 0.03% of the portfolio, ranked #615.

Voloridge Investment Management first reported a position in COLL in Q1 2019 and has held it in 12 quarters since. The position peaked at $11.5M in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Voloridge Investment Management held 200,306 shares of Collegium Pharmaceutical worth $6.62M as of Q1 2026.
  • Voloridge Investment Management sold 47,369 Collegium Pharmaceutical shares in Q1 2026, an estimated $2.01M.
  • Collegium Pharmaceutical made up 0.03% of Voloridge Investment Management's portfolio in Q1 2026, its #615 holding.
  • Voloridge Investment Management first reported a position in Collegium Pharmaceutical in Q1 2019 and has held it in 12 quarters since.
  • Voloridge Investment Management's Collegium Pharmaceutical position peaked at $11.5M in Q4 2025.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.